Zuzana Strizova (Z Strizova)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Journal of cancer research and clinical oncology

Biomedicines

Cancer immunology, immunotherapy : CII

Diagnostic pathology

University Hospital in Motol

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital in Motol Jun 30 2016

Czechia

MD/ PhD :: Department of Clinical Immunology

Publications

Ľudmila Křížová, Iva Benesova, Petra Zemanova, Jan Spacek, Zuzana Strizova, Zuzana Humlova, Veronika Mikulová, Lubos Petruzelka, Michal Vocka
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (2) (2024)
Ľudmila Křížová, Iva Benesova, Petra Zemanova, Jan Spacek, Zuzana Strizova, Zuzana Humlova, Veronika Mikulová, Lubos Petruzelka, Michal Vocka
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (2) (2024)
Ľudmila Křížová, Iva Benesova, Petra Zemanova, Jan Spacek, Zuzana Strizova, Zuzana Humlova, Veronika Mikulová, Lubos Petruzelka, Michal Vocka
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (2) (2024)
Ľudmila Křížová, Iva Benesova, Petra Zemanova, Jan Spacek, Zuzana Strizova, Zuzana Humlova, Veronika Mikulová, Lubos Petruzelka, Michal Vocka
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (2) (2024)
Ľudmila Křížová, Iva Benesova, Petra Zemanova, Jan Spacek, Zuzana Strizova, Zuzana Humlova, Veronika Mikulová, Lubos Petruzelka, Michal Vocka
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (2) (2024)
Ľudmila Křížová, Iva Benesova, Petra Zemanova, Jan Spacek, Zuzana Strizova, Zuzana Humlova, Veronika Mikulová, Lubos Petruzelka, Michal Vocka
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (2) (2024)
Jan Balko, Andrej Ozaniak, Lenka Krsková, Zuzana Strizova, Robert Lischke, Zamecnik Josef
Patient with composite haemangioendothelioma containing angiosarcoma-like areas in the setting of congenital lymphoedema mimicking Stewart-Treves syndrome: a case report. Diagnostic pathology 18 (1) (2023)
Jiri Vachtenheim, Rene Novysedlak, Monika Svorcova, Robert Lischke, Zuzana Strizova
How COVID-19 Affects Lung Transplantation: A Comprehensive Review. Journal of clinical medicine 11 (12) (2022)
Antonia Resag, Giulia Toffanin, Iva Benesova, Luise Rupp, Vlatko Potkrajcic, Andrej Ozaniak, Robert Lischke, Jirina Bartunkova, Antonio Rosato, Korinna Jöhrens, Franziska Eckert, Zuzana Strizova, Marc Schmitz
The Immune Contexture of Liposarcoma and Its Clinical Implications. Cancers 14 (19) (2022)
Martin Kuchar, Zuzana Strizova, Linda Capkova, Martin Komarc, Jiri Skrivan, Jirina Bartunkova, Daniel Smrz, Jan Plzák
The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor-Immune System Interplay. Biomedicines 9 (2) (2021)
Zuzana Strizova, Martin Kuchar, Linda Capkova, Martin Komarc, Jiri Skrivan, Jirina Bartunkova, Jan Plzak, Daniel Smrz
Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response. Biomedicines 9 (4) (2021)
Pavla Taborska, Jan Lastovicka, Dmitry Stakheev, Zuzana Strizova, Jirina Bartunkova, Daniel Smrz
SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors. Immunity, inflammation and disease 9 (4) (2021)
Andrej Ozaniak, Jiri Vachtenheim, Robert Lischke, Jirina Bartunkova, Zuzana Strizova
Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective? Biomedicines 9 (8) (2021)
Zuzana Strizova, Martin Snajdauf, Dmitry Stakheev, Pavla Taborska, Jiri Vachtenheim, Jan Biskup, Robert Lischke, Jirina Bartunkova, Daniel Smrz
The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients. Journal of cancer research and clinical oncology 146 (8) (2020)
Andrej Ozaniak, Zuzana Strizova, Pavel Hladik, Robert Lischke
Novel therapeutic approaches in the treatment of solitary fibrous tumors: A call for a combination therapy. Cancer 126 (17) (2020)
Zuzana Strizova, Jirina Bartunkova, Daniel Smrz
The challenges of adoptive cell transfer in the treatment of human renal cell carcinoma. Cancer immunology, immunotherapy : CII 68 (11) (2019)
Zuzana Strizova, J Vachtenheim, J Bartunkova
The potential role of neutrophil trogocytosis and G-CSF in the loss of HER2 expression. Breast cancer research and treatment 178 (1) (2019)

Zuzana Strizova.css-eqlu8i{font-size:small;padding-left:4px;} (Z Strizova)

Publication Activity (10 Years)

Top Topics

Top Venues

Zuzana Strizova (Z Strizova)